tb innovations
Tokyotbinnovations.co.jp
Overview
tb innovations is the corporate venture capital (CVC) arm of the Tokyo Boeki Group. It operates the 'Next New Business New Technology No. 1 Investment Limited Partnership' fund, which was established in April 2020. The firm invests in startups from seed to later stages, with a focus on middle and later-stage companies that can create synergies with the parent group. Its investment areas include life sciences, biotechnology, healthcare, AI, smart glass, and mobility SaaS.
Portfolio Companies
5
Website
tbinnovations.co.jpInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Nealle Inc. | Aug 2024 | Series B | Co-investor |
| RevComm Inc. | Jul 2024 | Series B | Co-investor |
| Mazrica Inc. | May 2023 | Series C | Co-investor |
| Future Standard | Mar 2022 | Corporate Funding | Lead |
| Infostellar Inc. | Jan 2022 | Series B | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
